UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

The New England journal of medicine, 2013-11, Vol.369 (19), p.1783-1796

2013

Volltextzugriff (PDF)

450 The impact of mental health comorbidities on patient satisfaction: A population study among U.S. adults with skin cancer

Journal of investigative dermatology, 2023-05, Vol.143 (5), p.S77-S77

2023

Volltextzugriff (PDF)

274 The impact of mental health comorbidities on patient satisfaction: A population study among U.S. adults with dermatitis

Journal of investigative dermatology, 2021-05, Vol.141 (5), p.S49

2021

Volltextzugriff (PDF)

373 Do less satisfied patients utilize more healthcare resources? A population study among U.S. adults with psoriasis

Journal of investigative dermatology, 2020-07, Vol.140 (7), p.S48-S48

2020

Volltextzugriff (PDF)

301 The impact of tailored delivery of education on engagement and disease severity: A randomized controlled trial among adults with psoriasis

Journal of investigative dermatology, 2022-08, Vol.142 (8), p.S51

2022

Volltextzugriff (PDF)

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib

Leukemia, 2008-06, Vol.22 (6), p.1200-1206

2008

Volltextzugriff (PDF)

Nilotinib in patients with Ph + chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results

Leukemia, 2012-06, Vol.26 (6), p.1189-1194

2012

Volltextzugriff (PDF)

Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles

Leukemia, 2010-01, Vol.24 (1), p.58-65

2010

Volltextzugriff (PDF)

KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib

Leukemia, 2012-02, Vol.26 (2), p.296-302

2012

Volltextzugriff (PDF)

hOCT1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemia

Leukemia, 2010-06, Vol.24 (6), p.1243-1245

2010

Volltextzugriff (PDF)

Pharmacokinetics of CAMPATH-1H in BMT patients

Cytotherapy (Oxford, England), 2001-07, Vol.3 (4), p.261-267

2001

Volltextzugriff (PDF)

Multiple sub-microscopic genomic lesions are a universal feature of chronic myeloid leukaemia at diagnosis

Leukemia, 2008-09, Vol.22 (9), p.1806-1807

2008

Volltextzugriff (PDF)

Factors for graft‐versus‐host disease after donor lymphocyte infusions with an escalating dose regimen: lack of association with cell dose

British journal of haematology, 2007-03, Vol.136 (6), p.833-836

2007

Volltextzugriff (PDF)

genes in chronic lymphocytic leukaemia: highly skewed V gene segment usage with similar CDR3 sequences

Leukemia, 2008-05, Vol.22 (5), p.1073

2008

Volltextzugriff (PDF)

Bone marrow transplantation for multiple myeloma

European journal of cancer (1990), 1999-09, Vol.35, p.S304-S304

Apperley, J.F.

1999

Volltextzugriff (PDF)

Mechanism and management of treatment-related gonadal failure in recipients of high dose chemoradiotherapy

Blood reviews, 1995-06, Vol.9 (2), p.93-116

1995

Volltextzugriff (PDF)

hOCT1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemia

Leukemia, 2010-06, Vol.24 (6), p.1243

2010

Volltextzugriff (PDF)

A simple FISH assay for the detection of 3q26 rearrangements in myeloid malignancy

Leukemia, 2008-02, Vol.22 (2), p.434-437

2008

Volltextzugriff (PDF)

33: Increased CD4+CD25high+ regulatory T-cell are associated with disease relapse after allogeneic stem cell transplantation (SCT) for chronic myeloid leukaemia (CML)

Biology of blood and marrow transplantation, 2007, Vol.13 (2), p.15-15

2007

Volltextzugriff (PDF)

Dasatinib (SPRYCEL®) Efficacy and Safety in Patients (pts) with Chronic Myelogenous Leukemia in Lymphoid (CML-LB) or Myeloid Blast (CML-MB) Phase Who Are Imatinib-Resistant (Im-r) or -Intolerant (Im-i)

Blood, 2006-11, Vol.108 (11), p.745-745

2006

Volltextzugriff (PDF)

Efficacy of Dasatinib (SPRYCEL®) in Patients (pts) with Chronic Phase Chronic Myelogenous Leukemia (CP-CML) Resistant to or Intolerant of Imatinib: Updated Results of the CA180013 ‘START-C' Phase II Study

Blood, 2006-11, Vol.108 (11), p.164-164

2006

Volltextzugriff (PDF)

HLA-B8 and HLA-A3 Coexpressed With HLA-B8 Are Associated With a Reduced Risk of the Development of Chronic Myeloid Leukemia

Blood, 1999-06, Vol.93 (11), p.3863-3865

1999

Volltextzugriff (PDF)

Dasatinib (SPRYCEL®) in Patients (pts) with Chronic Myelogenous Leukemia in Accelerated Phase (AP-CML) That Is Imatinib-Resistant (im-r) or -Intolerant (im-i): Updated Results of the CA180–005 'START-A' Phase II Study

Blood, 2006-11, Vol.108 (11), p.2160-2160

2006

Volltextzugriff (PDF)

A Phase II Study of Dasatinib in Patients with Accelerated Phase Chronic Myeloid Leukemia (CML) Who Are Resistant or Intolerant to Imatinib: First Results of the CA180005 ‘START-A' Study

Blood, 2005-11, Vol.106 (11), p.39-39

2005

Volltextzugriff (PDF)

Lymphoid transformation in a CML patient in complete cytogenetic remission following treatment with imatinib

Leukemia research, 2004-05, Vol.28, p.75-77

2004

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBone Marrow Transplantation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(42)

Sprache

Englisch
(42)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Humans
(25)
Life Sciences & Biomedicine
(25)
Biological And Medical Sciences
(21)
Hematology
(21)
Medical Sciences
(19)
Female
(16)
Male
(15)
Adult
(13)
Hematologic And Hematopoietic Diseases
(11)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(11)
Middle Aged
(11)
Oncology
(10)
Chronic Myeloid Leukemia
(9)
Leukemia
(9)
Aged
(7)
Bone Marrow Transplantation
(7)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(6)
Myeloid Leukemia
(6)
Patients
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

450 The impact of mental health comorbidities on patient satisfaction: A population study among U.S. adults with skin cancer

274 The impact of mental health comorbidities on patient satisfaction: A population study among U.S. adults with dermatitis

373 Do less satisfied patients utilize more healthcare resources? A population study among U.S. adults with psoriasis

301 The impact of tailored delivery of education on engagement and disease severity: A randomized controlled trial among adults with psoriasis

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib

Nilotinib in patients with Ph + chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results

Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles

KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib

hOCT1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemia

Pharmacokinetics of CAMPATH-1H in BMT patients

Multiple sub-microscopic genomic lesions are a universal feature of chronic myeloid leukaemia at diagnosis

Factors for graft‐versus‐host disease after donor lymphocyte infusions with an escalating dose regimen: lack of association with cell dose

genes in chronic lymphocytic leukaemia: highly skewed V gene segment usage with similar CDR3 sequences

Bone marrow transplantation for multiple myeloma

Mechanism and management of treatment-related gonadal failure in recipients of high dose chemoradiotherapy

hOCT1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemia

A simple FISH assay for the detection of 3q26 rearrangements in myeloid malignancy

33: Increased CD4+CD25high+ regulatory T-cell are associated with disease relapse after allogeneic stem cell transplantation (SCT) for chronic myeloid leukaemia (CML)

Dasatinib (SPRYCEL®) Efficacy and Safety in Patients (pts) with Chronic Myelogenous Leukemia in Lymphoid (CML-LB) or Myeloid Blast (CML-MB) Phase Who Are Imatinib-Resistant (Im-r) or -Intolerant (Im-i)

Efficacy of Dasatinib (SPRYCEL®) in Patients (pts) with Chronic Phase Chronic Myelogenous Leukemia (CP-CML) Resistant to or Intolerant of Imatinib: Updated Results of the CA180013 ‘START-C' Phase II Study

HLA-B8 and HLA-A3 Coexpressed With HLA-B8 Are Associated With a Reduced Risk of the Development of Chronic Myeloid Leukemia

Dasatinib (SPRYCEL®) in Patients (pts) with Chronic Myelogenous Leukemia in Accelerated Phase (AP-CML) That Is Imatinib-Resistant (im-r) or -Intolerant (im-i): Updated Results of the CA180–005 'START-A' Phase II Study

A Phase II Study of Dasatinib in Patients with Accelerated Phase Chronic Myeloid Leukemia (CML) Who Are Resistant or Intolerant to Imatinib: First Results of the CA180005 ‘START-A' Study

Lymphoid transformation in a CML patient in complete cytogenetic remission following treatment with imatinib

Aktive Filter

Suchergebnisse filtern